SELP and breast carcinoma: In breast cancer patients, ADAM17 expression on the surface of activated platelets was lower compared with resting (CD62P-negative) platelets and pADAM17 downregulation was positively related to basal ADAM17 expression on resting platelets, which may indicate that pADAM17 expression is regulated upon platelet activation in the context of breast cancer.